Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. ABBV
5. NAVN
6. CNC
7. KFY
8. MU
9. DPZ
10. PLTR

Go back to Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update

Gossamer Bio Inc. (GOSS) Misses Q4 EPS by 2c, Beats on Revenue

March 17, 2026 4:13 PM EDT

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q4 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $7.52 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

... More